KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Insulet (PODD) EBT (2016 - 2025)

Insulet's EBT history spans 16 years, with the latest figure at $140.2 million for Q4 2025.

  • For Q4 2025, EBT rose 25.85% year-over-year to $140.2 million; the TTM value through Dec 2025 reached $339.5 million, up 13.05%, while the annual FY2025 figure was $339.5 million, 13.09% up from the prior year.
  • EBT reached $140.2 million in Q4 2025 per PODD's latest filing, up from $122.8 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $140.2 million in Q4 2025 to a low of -$36.1 million in Q2 2022.
  • Average EBT over 5 years is $44.2 million, with a median of $31.4 million recorded in 2021.
  • Peak YoY movement for EBT: crashed 263.22% in 2021, then surged 9666.67% in 2022.
  • A 5-year view of EBT shows it stood at $33.4 million in 2021, then plummeted by 33.23% to $22.3 million in 2022, then skyrocketed by 383.86% to $107.9 million in 2023, then rose by 3.24% to $111.4 million in 2024, then rose by 25.85% to $140.2 million in 2025.
  • Per Business Quant, the three most recent readings for PODD's EBT are $140.2 million (Q4 2025), $122.8 million (Q3 2025), and $28.4 million (Q2 2025).